Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -20.250\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) CN(C(=O)CCc1ccccc1F)C1CCCN(Cc2ccccc2F)C1
(b) Cc1cc(C(=O)N/N=C/c2cccnc2)c(C)o1
(c) CCOC(=O)c1nc(NCc2cccnc2)c2ccccc2n1
(d) Cc1ccc(C(=O)Cn2c(=N)n(CCN3CCOCC3)c3ccccc32)cc1.[Br-]
(e) CC1SC(=NC(=O)c2ccncc2)NC1=O
Answer: d. Cc1ccc(C(=O)Cn2c(=N)n(CCN3CCOCC3)c3ccccc32)cc1.[Br-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C(=O)Cn2c(=N)n(CCN3CCOCC3)c3ccccc32)cc1.[Br-]
Cc1ccc(C(=O)Cn2c(=N)n(CCN3CCOCC3)c3ccccc32)cc1.[Br-]
2-[2-imino-3-(2-morpholin-4-ylethyl)benzimidazol-1-yl]-1-(4-methylphenyl)ethanone;bromide